Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 1276

1.

Acute esophageal necrosis following cellulitis in an obese patient with diabetes mellitus.

Tanaka S, Fujishiro M, Ichijima R, Kohno G, Abe M, Ishihara H.

J Diabetes Investig. 2019 Jun 20. doi: 10.1111/jdi.13104. [Epub ahead of print]

2.

Hemichorea after hypoglycemic episodes with negative MRI findings in an elderly woman with poorly controlled type 2 diabetes mellitus: a case report.

Matsushima E, Shiota H, Watanabe K, Otsuka Y, Yamana M, Yamaguchi S, Egashira F, Kamei S, Ishihara H.

BMC Neurol. 2019 Jun 15;19(1):131. doi: 10.1186/s12883-019-1334-2.

3.

Ultrafast thermal-free photoluminescence of coherently extended single quantum states.

Matsuda T, Ichimiya M, Ashida M, Ishihara H.

Sci Rep. 2019 Jun 11;9(1):8453. doi: 10.1038/s41598-019-44940-7.

4.

Newly developing brain metastases during nivolumab therapy for metastatic renal cell carcinoma: A case series in two Japanese institutions.

Ishihara H, Kondo T, Takagi T, Yoshida K, Okumi M, Tanabe K.

Int J Urol. 2019 May 21. doi: 10.1111/iju.14020. [Epub ahead of print] No abstract available.

PMID:
31115103
5.

Safety and Efficacy of Nivolumab in Patients With Metastatic Renal Cell Carcinoma and End-stage Renal Disease at 2 Centers.

Tachibana H, Kondo T, Ishihara H, Takagi T, Tanabe K.

Clin Genitourin Cancer. 2019 Apr 17. pii: S1558-7673(19)30130-2. doi: 10.1016/j.clgc.2019.04.004. [Epub ahead of print]

PMID:
31101580
6.

Synergetic Enhancement of Light-Matter Interaction by Nonlocality and Band Degeneracy in ZnO Thin Films.

Kinoshita T, Matsuda T, Takahashi T, Ichimiya M, Ashida M, Furukawa Y, Nakayama M, Ishihara H.

Phys Rev Lett. 2019 Apr 19;122(15):157401. doi: 10.1103/PhysRevLett.122.157401.

PMID:
31050541
7.

Risk of Deterioration of Geriatric Traumatic Brain Injury in Patients Treated with Antithrombotic Drugs.

Suehiro E, Fujiyama Y, Kiyohira M, Haji K, Ishihara H, Nomura S, Suzuki M; Japan Neurotrauma Data Bank Committee.

World Neurosurg. 2019 Apr 19. pii: S1878-8750(19)31102-7. doi: 10.1016/j.wneu.2019.04.108. [Epub ahead of print]

PMID:
31009773
8.

Primed histone demethylation regulates shoot regenerative competency.

Ishihara H, Sugimoto K, Tarr PT, Temman H, Kadokura S, Inui Y, Sakamoto T, Sasaki T, Aida M, Suzuki T, Inagaki S, Morohashi K, Seki M, Kakutani T, Meyerowitz EM, Matsunaga S.

Nat Commun. 2019 Apr 16;10(1):1786. doi: 10.1038/s41467-019-09386-5.

9.

Association between immune-related adverse events and prognosis in patients with metastatic renal cell carcinoma treated with nivolumab.

Ishihara H, Takagi T, Kondo T, Homma C, Tachibana H, Fukuda H, Yoshida K, Iizuka J, Kobayashi H, Okumi M, Ishida H, Tanabe K.

Urol Oncol. 2019 Jun;37(6):355.e21-355.e29. doi: 10.1016/j.urolonc.2019.03.003. Epub 2019 Mar 29.

PMID:
30935847
10.

Prognostic Markers for Refined Stratification of IMDC Intermediate-Risk Metastatic Clear Cell Renal Cell Carcinoma Treated with First-Line Tyrosine Kinase Inhibitor Therapy.

Takagi T, Fukuda H, Kondo T, Ishihara H, Yoshida K, Kobayashi H, Iizuka J, Okumi M, Ishida H, Tanabe K.

Target Oncol. 2019 Apr;14(2):179-186. doi: 10.1007/s11523-019-00634-8.

PMID:
30927174
11.

Efficacy of axitinib in patients with metastatic renal cell carcinoma refractory to nivolumab therapy.

Yoshida K, Takagi T, Kondo T, Kobayashi H, Iizuka J, Fukuda H, Ishihara H, Okumi M, Ishida H, Tanabe K.

Jpn J Clin Oncol. 2019 Jun 1;49(6):576-580. doi: 10.1093/jjco/hyz040.

PMID:
30924496
12.

Impact of Frailty on Medium-Term Outcome in Asymptomatic Patients After Carotid Artery Stenting.

Ishihara H, Oka F, Goto H, Nishimoto T, Okazaki K, Sadahiro H, Kawano R, Suzuki M.

World Neurosurg. 2019 Mar 23. pii: S1878-8750(19)30813-7. doi: 10.1016/j.wneu.2019.03.135. [Epub ahead of print]

PMID:
30910751
13.

Prolyl Isomerase Pin1 Suppresses Thermogenic Programs in Adipocytes by Promoting Degradation of Transcriptional Co-activator PRDM16.

Nakatsu Y, Matsunaga Y, Yamamotoya T, Ueda K, Inoue MK, Mizuno Y, Nakanishi M, Sano T, Yamawaki Y, Kushiyama A, Sakoda H, Fujishiro M, Ryo A, Ono H, Minamino T, Takahashi SI, Ohno H, Yoneda M, Takahashi K, Ishihara H, Katagiri H, Nishimura F, Kanematsu T, Yamada T, Asano T.

Cell Rep. 2019 Mar 19;26(12):3221-3230.e3. doi: 10.1016/j.celrep.2019.02.066.

14.

Correlation between the magnitude of best tumor response and patient survival in nivolumab therapy for metastatic renal cell carcinoma.

Ishihara H, Takagi T, Kondo T, Tachibana H, Fukuda H, Yoshida K, Iizuka J, Kobayashi H, Okumi M, Ishida H, Tanabe K.

Med Oncol. 2019 Mar 16;36(4):35. doi: 10.1007/s12032-019-1261-5.

PMID:
30879157
15.

Efficacy and safety of ipragliflozin as add-on therapy to insulin in Japanese patients with type 2 diabetes mellitus (IOLITE): a 36-week, open-label extension of a 16-week, randomized, placebo-controlled, double-blind study.

Ishihara H, Yamaguchi S, Nakao I, Asahina S, Sakatani T.

Diabetol Int. 2018 Jul 16;10(1):37-50. doi: 10.1007/s13340-018-0359-x. eCollection 2019 Jan.

PMID:
30800562
16.

[Characterization and Analytical Techniques for Nano-DDS Formulations].

Ishihara H, Sakai-Kato K.

Yakugaku Zasshi. 2019;139(2):235-236. doi: 10.1248/yakushi.18-00171-F. Japanese. No abstract available.

17.

β-Hydroxy-β-methyl Butyrate/L-Arginine/L-Glutamine Supplementation for Preventing Hand-Foot Skin Reaction in Sorafenib for Advanced Hepatocellular Carcinoma.

Naganuma A, Hoshino T, Ohno N, Ogawa Y, Murakami T, Horiguchi S, Uehara D, Suzuki Y, Hatanaka T, Kudo T, Ishihara H, Sato K, Kakizaki S, Takagi H.

In Vivo. 2019 Jan-Feb;33(1):155-161. doi: 10.21873/invivo.11452.

18.

Kinetics of cytokine mRNA and protein expression by plastic adherent cells in the thymus after split-dose irradiation.

Nagayasu A, Kakinuma S, Nishimura M, Shang Y, Sunaoshi M, Tsuruoka C, Ishihara H, Shimada Y, Kobayashi Y.

Cytokine. 2019 Feb;114:92-97. doi: 10.1016/j.cyto.2018.11.006. Epub 2018 Nov 19.

PMID:
30467095
19.

Elsberg syndrome related to varicella zoster virus infection with painless skin lesions in an elderly woman with poorly controlled type 2 diabetes mellitus.

Saito H, Ebashi M, Kushimoto M, Ikeda J, Egashira F, Yamaguchi S, Watanabe K, Ogawa K, Suzuki Y, Ishihara H, Fujishiro M.

Ther Clin Risk Manag. 2018 Oct 9;14:1951-1954. doi: 10.2147/TCRM.S178782. eCollection 2018.

20.

Cilostazol decreases duration of spreading depolarization and spreading ischemia after aneurysmal subarachnoid hemorrhage.

Sugimoto K, Nomura S, Shirao S, Inoue T, Ishihara H, Kawano R, Kawano A, Oka F, Suehiro E, Sadahiro H, Shinoyama M, Oku T, Maruta Y, Hirayama Y, Hiyoshi K, Kiyohira M, Yoneda H, Okazaki K, Dreier JP, Suzuki M.

Ann Neurol. 2018 Dec;84(6):873-885. doi: 10.1002/ana.25361. Epub 2018 Nov 29.

PMID:
30341966
21.

Effect of Changes in Skeletal Muscle Mass on Oncological Outcomes During First-Line Sunitinib Therapy for Metastatic Renal Cell Carcinoma.

Ishihara H, Takagi T, Kondo T, Fukuda H, Yoshida K, Iizuka J, Tanabe K.

Target Oncol. 2018 Dec;13(6):745-755. doi: 10.1007/s11523-018-0600-3.

PMID:
30328067
22.

Cerebral infarction associated with benign mucin-producing adenomyosis: report of two cases.

Okazaki K, Oka F, Ishihara H, Suzuki M.

BMC Neurol. 2018 Oct 4;18(1):166. doi: 10.1186/s12883-018-1169-2.

23.

Immediate Progressive Disease in Patients with Metastatic Renal Cell Carcinoma Treated with Nivolumab: a Multi-Institution Retrospective Study.

Ishihara H, Kondo T, Takagi T, Tachibana H, Fukuda H, Yoshida K, Iizuka J, Kobayashi H, Tanabe K.

Target Oncol. 2018 Oct;13(5):611-619. doi: 10.1007/s11523-018-0591-0.

PMID:
30232691
24.

DNA methylation marker to estimate the breast cancer cell fraction in DNA samples.

Ishihara H, Yamashita S, Fujii S, Tanabe K, Mukai H, Ushijima T.

Med Oncol. 2018 Sep 14;35(11):147. doi: 10.1007/s12032-018-1207-3.

PMID:
30218172
25.

Acquired cystic disease-associated renal cell carcinoma is the most common subtype in long-term dialyzed patients: Central pathology results according to the 2016 WHO classification in a multi-institutional study.

Kondo T, Sasa N, Yamada H, Takagi T, Iizuka J, Kobayashi H, Yoshida K, Fukuda H, Ishihara H, Tanabe K, Tsuzuki T.

Pathol Int. 2018 Oct;68(10):543-549. doi: 10.1111/pin.12718. Epub 2018 Sep 6.

PMID:
30187581
26.

Pancreatic Cancer Cell Fraction Estimation in a DNA Sample.

Ishihara H, Yamashita S, Amano R, Kimura K, Hirakawa K, Ueda T, Murakami Y, Tamori A, Tanabe K, Kawada N, Hagihara A, Ushijima T.

Oncology. 2018;95(6):370-379. doi: 10.1159/000491637. Epub 2018 Aug 27.

PMID:
30149376
27.

Rationale and Design of the STOP-OB Study for Evaluating the Effects of Tofogliflozin and Glimepiride on Fat Deposition in Type 2 Diabetes Patients Treated with Metformin/DPP-4 Inhibitor Dual Therapy.

Ishihara H, Anai M, Seino H, Kitazawa T, Ohashi H, Ai M, Inoue M, Fujishiro M, Inazawa T, Kuroda H, Yamada M.

Diabetes Ther. 2018 Oct;9(5):2117-2125. doi: 10.1007/s13300-018-0491-4. Epub 2018 Aug 25.

28.

Impact of the Mayo Adhesive Probability Score on the Complexity of Robot-Assisted Partial Nephrectomy.

Ishiyama R, Kondo T, Takagi T, Iizuka J, Kobayashi H, Omae K, Fukuda H, Ishihara H, Tanabe K.

J Endourol. 2018 Oct;32(10):928-933. doi: 10.1089/end.2017.0779. Epub 2018 Sep 25.

PMID:
30141346
29.

Durable response after discontinuation of nivolumab therapy in patients with metastatic renal cell carcinoma.

Takagi T, Yoshida K, Kobayashi H, Kondo T, Iizuka J, Okumi M, Ishida H, Fukuda H, Ishihara H, Tanabe K.

Jpn J Clin Oncol. 2018 Sep 1;48(9):860-863. doi: 10.1093/jjco/hyy106.

PMID:
30113653
30.

Risk factors for severity of colonic diverticular hemorrhage.

Kinjo K, Matsui T, Hisabe T, Ishihara H, Kojima T, Chuman K, Yasukawa S, Beppu T, Koga A, Ishikawa S, Kishi M, Takatsu N, Hirai F, Yao K, Ueki T, Washio M.

Intest Res. 2018 Jul;16(3):458-466. doi: 10.5217/ir.2018.16.3.458. Epub 2018 Jul 27.

31.

Development of a powered variable-stiffness exoskeleton device for elbow rehabilitation.

Liu Y, Guo S, Hirata H, Ishihara H, Tamiya T.

Biomed Microdevices. 2018 Aug 3;20(3):64. doi: 10.1007/s10544-018-0312-6.

PMID:
30074095
32.

Thrombolysis with rt-PA under Rivaroxaban Anticoagulation in a Hypertensive Rat Model of Intraluminal Middle Cerebral Artery Occlusion.

Izuma H, Oka F, Ishihara H, Inoue T, Suehiro E, Nomura S, Suzuki M.

J Stroke Cerebrovasc Dis. 2018 Oct;27(10):2761-2767. doi: 10.1016/j.jstrokecerebrovasdis.2018.06.003. Epub 2018 Jul 25.

PMID:
30056000
33.

Glottic cancer in patients without complaints of hoarseness.

Tachibana T, Orita Y, Marunaka H, Makihara S, Hirai M, Miki K, Ogawara Y, Ishihara H, Matsuyama Y, Abe-Fujisawa I, Shimizu A, Sato Y, Nishizaki K.

Head Neck. 2018 Jul;40(7):1608. doi: 10.1002/hed.25196. Epub 2018 Mar 31. No abstract available.

PMID:
29984522
34.

A case of drug induced lung injury caused by levofloxacin eye drops.

Hosogaya N, Toida K, Ishihara H, Kugiyama K.

Respir Med Case Rep. 2018 Mar 16;24:12-15. doi: 10.1016/j.rmcr.2018.03.010. eCollection 2018.

35.

Ipragliflozin Add-on Therapy to a GLP-1 Receptor Agonist in Japanese Patients with Type 2 Diabetes (AGATE): A 52-Week Open-Label Study.

Ishihara H, Yamaguchi S, Nakao I, Sakatani T.

Diabetes Ther. 2018 Aug;9(4):1549-1567. doi: 10.1007/s13300-018-0455-8. Epub 2018 Jun 20.

36.

Performance evaluation of a robot-assisted catheter operating system with haptic feedback.

Song Y, Guo S, Yin X, Zhang L, Hirata H, Ishihara H, Tamiya T.

Biomed Microdevices. 2018 Jun 20;20(2):50. doi: 10.1007/s10544-018-0294-4.

PMID:
29926195
37.

Decreased relative dose intensity during the early phase of treatment impacts the therapeutic efficacy of sunitinib in metastatic renal cell carcinoma.

Ishihara H, Takagi T, Kondo T, Iwamoto K, Tachibana H, Yoshida K, Omae K, Iizuka J, Kobayashi H, Tanabe K.

Jpn J Clin Oncol. 2018 Jul 1;48(7):667-672. doi: 10.1093/jjco/hyy078.

PMID:
29860353
38.

Prognostic Impact of the Components of Progressive Disease on Survival After First-Line Tyrosine Kinase Inhibitor Therapy for Metastatic Renal Cell Carcinoma.

Ikeda T, Ishihara H, Takagi T, Kondo T, Yoshida K, Iizuka J, Tanabe K.

Target Oncol. 2018 Jun;13(3):379-387. doi: 10.1007/s11523-018-0569-y.

PMID:
29785576
39.

Peri-stent contrast staining post-everolimus eluting stent deployment disappeared in a very short duration.

Maeda T, Teramoto T, Tanaka N, Ishihara H, Teramura M, Ichihashi K.

Cardiovasc Interv Ther. 2019 Apr;34(2):184-186. doi: 10.1007/s12928-018-0528-7. Epub 2018 May 11. No abstract available.

PMID:
29752590
40.

A randomized, double-blind, placebo-controlled Phase III trial of duloxetine in Japanese patients with knee pain due to osteoarthritis.

Uchio Y, Enomoto H, Alev L, Kato Y, Ishihara H, Tsuji T, Ochiai T, Konno S.

J Pain Res. 2018 Apr 18;11:809-821. doi: 10.2147/JPR.S164128. eCollection 2018.

41.

Evaluation of relative dose intensity during the early phase of first-line sunitinib treatment using a 2-week-on/1-week-off regimen for metastatic renal cell carcinoma.

Iwamoto K, Ishihara H, Takagi T, Kondo T, Yoshida K, Iizuka J, Tanabe K.

Med Oncol. 2018 Apr 23;35(6):78. doi: 10.1007/s12032-018-1139-y.

PMID:
29687160
42.

Idiopathic basal ganglia calcification associated with cerebral micro-infarcts: a case report.

Nishimoto T, Oka F, Ishihara H, Shinoyama M, Suzuki M.

BMC Neurol. 2018 Apr 17;18(1):42. doi: 10.1186/s12883-018-1048-x.

43.

Obesity does not affect peri- and postoperative outcomes of transabdominal laparoscopic adrenalectomy.

Inaishi T, Kikumori T, Takeuchi D, Ishihara H, Miyajima N, Shibata M, Takano Y, Nakanishi K, Noda S, Kodera Y.

Nagoya J Med Sci. 2018 Feb;80(1):21-28. doi: 10.18999/nagjms.80.1.21.

44.

Simulation of Stimuli-Responsive and Stoichiometrically Controlled Release Rate of Doxorubicin from Liposomes in Tumor Interstitial Fluid.

Yamamoto E, Hyodo K, Suzuki T, Ishihara H, Kikuchi H, Kato M.

Pharm Res. 2018 Mar 19;35(5):103. doi: 10.1007/s11095-018-2380-y.

PMID:
29557075
45.

Design and performance evaluation of collision protection-based safety operation for a haptic robot-assisted catheter operating system.

Zhang L, Guo S, Yu H, Song Y, Tamiya T, Hirata H, Ishihara H.

Biomed Microdevices. 2018 Feb 23;20(2):22. doi: 10.1007/s10544-018-0266-8. Review.

PMID:
29476379
46.

Generation and Characterization of a Novel Small Biologic Alternative to Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) Antibodies, DS-9001a, Albumin Binding Domain-Fused Anticalin Protein.

Masuda Y, Yamaguchi S, Suzuki C, Aburatani T, Nagano Y, Miyauchi R, Suzuki E, Yamamura N, Nagatomo K, Ishihara H, Okuno K, Nara F, Matschiner G, Hashimoto R, Takahashi T, Nishizawa T.

J Pharmacol Exp Ther. 2018 May;365(2):368-378. doi: 10.1124/jpet.117.246652. Epub 2018 Feb 20.

PMID:
29463608
47.

Mexican-Hat-Like Response in a Flexible Tactile Sensor Using a Magnetorheological Elastomer.

Kawasetsu T, Horii T, Ishihara H, Asada M.

Sensors (Basel). 2018 Feb 14;18(2). pii: E587. doi: 10.3390/s18020587.

48.

Validity of conventional endoscopy using "non-extension sign" for optical diagnosis of colorectal deep submucosal invasive cancer.

Hisabe T, Tsuda S, Hoashi T, Ishihara H, Yamasaki K, Yasaka T, Hirai F, Matsui T, Yao K, Tanabe H, Iwashita A.

Endosc Int Open. 2018 Feb;6(2):E156-E164. doi: 10.1055/s-0043-121881. Epub 2018 Feb 1.

49.

Efficacy and safety of third-line molecular-targeted therapy in metastatic renal cell carcinoma resistant to first-line vascular endothelial growth factor receptor tyrosine kinase inhibitor and second-line therapy.

Ishihara H, Takagi T, Kondo T, Tachibana H, Yoshida K, Omae K, Iizuka J, Kobayashi H, Tanabe K.

Int J Clin Oncol. 2018 Jun;23(3):559-567. doi: 10.1007/s10147-018-1241-3. Epub 2018 Jan 11.

PMID:
29327159
50.

[Effect of Platelet Concentrate Transfusion on Prognosis of Patients with Intracerebral Hemorrhage Treated with Anti-Platelet Agents].

Sugimoto K, Ishihara H, Shinoyama M, Sadahiro H, Suzuki M.

No Shinkei Geka. 2017 Nov;45(11):965-970. doi: 10.11477/mf.1436203629. Japanese.

PMID:
29172201

Supplemental Content

Loading ...
Support Center